Institutional Investors Lead Shift in Nxstage Medical Inc (NASDAQ:NXTM) Sentiment

April 17, 2018 - By Adrian Mccoy

Nxstage Medical, Inc. (NASDAQ:NXTM) Logo

Sentiment for Nxstage Medical Inc (NASDAQ:NXTM)

Nxstage Medical Inc (NASDAQ:NXTM) institutional sentiment increased to 1.25 in Q4 2017. Its up 0.34, from 0.91 in 2017Q3. The ratio has improved, as 79 hedge funds increased and opened new holdings, while 63 reduced and sold stock positions in Nxstage Medical Inc. The hedge funds in our partner’s database now have: 47.78 million shares, down from 51.56 million shares in 2017Q3. Also, the number of hedge funds holding Nxstage Medical Inc in their top 10 holdings increased from 3 to 7 for an increase of 4. Sold All: 22 Reduced: 41 Increased: 48 New Position: 31.

NxStage Medical, Inc., a medical technology company, develops, makes, and markets services and products for patients suffering from chronic or acute kidney failure. The company has market cap of $1.72 billion. The Company’s primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. It currently has negative earnings. The firm operates through three divisions: System One, In-Center, and Services.

The stock increased 0.57% or $0.147 during the last trading session, reaching $25.947. About 24,681 shares traded. Nxstage Medical, Inc. (NASDAQ:NXTM) has declined 9.81% since April 17, 2017 and is downtrending. It has underperformed by 21.36% the S&P500.

Burren Capital Advisors Ltd holds 4.82% of its portfolio in Nxstage Medical, Inc. for 33,550 shares. Falcon Edge Capital Lp owns 791,000 shares or 4.39% of their US portfolio. Moreover, Pennant Capital Management Llc has 3.86% invested in the company for 1.76 million shares. The New Jersey-based Alpine Associates Management Inc. has invested 3.5% in the stock. Dafna Capital Management Llc, a California-based fund reported 216,119 shares.#img1#

Since January 1, 0001, it had 0 buys, and 4 sales for $379,835 activity.

Nxstage Medical, Inc. (NASDAQ:NXTM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.